Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier‐Free Nanoassembly of Fluorinated Prodrug and siRNA
Pengkai Wu, Haitian Zhang, Meiling Sun, et al.
Advanced Materials (2022) Vol. 34, Iss. 38
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Continuous Spatiotemporal Therapy of A Full-API Nanodrug via Multi-Step Tandem Endogenous Biosynthesis
Fang Fang, Sa Wang, Yueyue Song, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy
Jianfeng Guo, Yifang Zou, Leaf Huang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 55
Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 46
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 28
Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview
Xu Liu, Cheng Yang, Yao Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Transforming Intratumor Bacteria into Immunopotentiators to Reverse Cold Tumors for Enhanced Immuno-chemodynamic Therapy of Triple-Negative Breast Cancer
Xuemeng Liu, Mengyu Sun, Fang Pu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 48, pp. 26296-26307
Closed Access | Times Cited: 42
From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
Hanmeng Liu, Wei Shen, Wanguo Liu, et al.
Bioactive Materials (2023) Vol. 31, pp. 206-230
Open Access | Times Cited: 27
Light‐Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy
Jiwoong Choi, Byeongmin Park, Jung Yeon Park, et al.
Advanced Materials (2024) Vol. 36, Iss. 38
Closed Access | Times Cited: 14
Melittin and phospholipase A2: Promising anti-cancer candidates from bee venom
Ziyan Cui, Zegao Zhou, Ziyan Sun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117385-117385
Open Access | Times Cited: 9
Tailoring carrier-free nanocombo of small-molecule prodrug for combinational cancer therapy
Haonan Li, Wenli Zang, Zhen Mi, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 256-275
Closed Access | Times Cited: 33
Carrier-Free Nanodrugs: From Bench to Bedside
Fang Fang, Xiaoyuan Chen
ACS Nano (2024) Vol. 18, Iss. 35, pp. 23827-23841
Closed Access | Times Cited: 8
A Triple‐Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H2O2 Self‐Generation for Imaging‐Guided Tumor Chemo‐Ferroptosis‐Immunotherapy
Yongjuan Li, Yongjian Cao, Kunru Ma, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 7
Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment
Lingxi Jiang, Qi Yao, Lei Yang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 5, pp. 100852-100852
Open Access | Times Cited: 15
Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma
Linlin Li, Yifang Zou, Lingzhi Wang, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123114-123114
Closed Access | Times Cited: 14
An Immunomodulatory Zinc‐Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte‐Assisted Cascade Immune Activation
Jing Zhao, Lingxiao Zhang, Li Pin, et al.
Advanced Science (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 14
Microfluidics-enabled fluorinated assembly of EGCG-ligands-siTOX nanoparticles for synergetic tumor cells and exhausted t cells regulation in cancer immunotherapy
Xiaowei Han, Guozheng Zhang, Xiaozhen Wu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Design, synthesis and biological evaluation of the positional isomers of the galactose conjugates able to target hepatocellular carcinoma cells via ASGPR-mediated cellular uptake and cytotoxicity
Wenchong Ye, Qun Tang, Tiantian Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115988-115988
Closed Access | Times Cited: 12
A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy
Amirhossein Bahreyni, Huitao Liu, Yasir Mohamud, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Engineered platelets-based nano-aircraft system for precise tumor chemo-immunotherapy with graded drug delivery and self-recognized tumor targeting
Meijuan Geng, Huiping Du, Xuan Wei, et al.
Science Bulletin (2025)
Closed Access
Intraductal chemotherapy for triple-negative breast cancer: a pathway to minimally invasive clinical treatment
Xinhong Wu, Yuan Feng, Liantao Guo, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Copper-based hollow mesoporous nanogenerator with reactive oxygen species and reactive nitrogen species storm generation for self-augmented immunogenic cell death-mediated triple-negative breast cancer immunotherapy
Quan Jing, Jinlong Zhang, L. Yuan, et al.
Journal of Colloid and Interface Science (2025) Vol. 688, pp. 688-702
Closed Access
NIR-II Light-driven genetically edited nanoparticles with inherent CRT-inducing capability for macrophage-mediated immunotherapy
Qiaoyi Huang, Miao Su, Liang Zhao, et al.
Nano Today (2023) Vol. 50, pp. 101857-101857
Closed Access | Times Cited: 10
Molecular insight into T cell exhaustion in hepatocellular carcinoma
Yonghua Zhu, Huabing Tan, Jincheng Wang, et al.
Pharmacological Research (2024) Vol. 203, pp. 107161-107161
Open Access | Times Cited: 3
A cisplatin prodrug-based self-assembling ozone delivery nanosystem sensitizes radiotherapy in triple-negative breast cancer
Tianyue Xu, Dan Zheng, Meixu Chen, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Page 1 - Next Page

Scroll to top